Skip to main content

Advertisement

SpringerLink
Log in

Weight change and its impact on prognosis after adjuvant TAC (docetaxel–doxorubicin–cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The aim of this study was to characterize weight changes and analyze their effect on prognosis after three-drug combination chemotherapy using docetaxel, doxorubicin and cyclophosphamide (TAC) chemotherapy in Korean women with breast cancer. We analyzed weight changes and the effect of these changes on relapse-free survival (RFS) in 108 patients who received adjuvant TAC chemotherapy at the Department of Surgery of St. Vincent’s Hospital at the Catholic University of Korea between January 2005 and March 2010. Following chemotherapy, 59 (54.6 %) patients experienced weight gain, with their weight significantly increasing compared to their weight at diagnosis (p < 0.0001). However, weight gain after chemotherapy was not associated with RFS [hazard ratio (HR) 1.1; 95 % confidence interval (CI) 0.4–3.0; p = 0.8955]. No significant weight (at 12 months, p = 0.522; at 24 months, p = 0.632) and body mass index (BMI) (at 12 months, p = 0.381; at 24 months, p = 0.288) changes were observed compared to the weight and BMI at diagnosis, and weight change at 12 months (HR 1.9; 95 % CI 0.6–6.1; p = 0.2786) and 24 months (HR 2.7; 95 % CI 0.9–8.4; p = 0.0776) was not associated with RFS. The present study suggests that weight gain after adjuvant TAC chemotherapy is common in Korean women with breast cancer. In contrast to previous Western studies, weight gain did not appear to be sustained, and there was no relationship between weight gain and poor RFS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosed with breast cancer. J Am Diet Assoc. 1997;97:519–26.

    Article  CAS  PubMed  Google Scholar 

  2. Goodwin PJ, Ennis M, Pritchard KI, McCready D, Koo J, Sidlofsky S, Trudeau M, Hood N, Redwood S. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol. 1999;17:120–9.

    CAS  PubMed  Google Scholar 

  3. Goodwin PJ. Weight gain in early-stage breast cancer: where do we go from here? J Clin Oncol. 2001;19:2367–9.

    CAS  PubMed  Google Scholar 

  4. Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, Marcom PK, Blackwell K, Rimer BK. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2001;19:2381–9.

    CAS  PubMed  Google Scholar 

  5. Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Gilliland FD, Ballard-Barbash R. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol. 2005;23:774–82.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol. 1990;8:1327–34.

    CAS  PubMed  Google Scholar 

  7. Saquib N, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, Caan B, Rock CL, Pierce JP. Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the Women’s Healthy Eating and Living (WHEL) study. Breast Cancer Res Treat. 2007;105:177–86.

    Article  PubMed  Google Scholar 

  8. Harvie MN, Campbell IT, Baildam A, Howell A. Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat. 2004;83:201–10.

    Article  CAS  PubMed  Google Scholar 

  9. Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, Stefanick ML, Faerber S, Pierce JP. Factors associated with weight gain in women after diagnosis of breast cancer. Women’s Healthy Eating and Living Study Group. J Am Diet Assoc. 1999;99:1212–21.

    Article  CAS  PubMed  Google Scholar 

  10. Levine EG, Raczynski JM, Carpenter JT. Weight gain with breast cancer adjuvant treatment. Cancer. 1991;67:1954–9.

    Article  CAS  PubMed  Google Scholar 

  11. Makari-Judson G, Judson CH, Mertens WC. Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year. Breast J. 2007;13:258–65.

    Article  PubMed  Google Scholar 

  12. Conroy SM, Maskarinec G, Wilkens LR, White KK, Henderson BE, Kolonel LN. Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study. Breast Cancer Res Treat. 2011;129:565–74.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Ewertz M, Jensen MB, Gunnarsdóttir KÁ, Højris I, Jakobsen EH, Nielsen D, Stenbygaard LE, Tange UB, Cold S. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol. 2011;29:25–31.

    Article  PubMed  Google Scholar 

  14. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123:627–35.

    Article  PubMed  Google Scholar 

  15. Kwan ML, Chen WY, Kroenke CH, Weltzien EK, Beasley JM, Nechuta SJ, Poole EM, Lu W, Holmes MD, Quesenberry CP Jr, Pierce JP, Shu XO, Caan BJ. Pre-diagnosis body mass index and survival after breast cancer in the after breast cancer pooling project. Breast Cancer Res Treat. 2012;132:729–39.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23:1370–8.

    Article  PubMed  Google Scholar 

  17. Caan BJ, Emond JA, Natarajan L, Castillo A, Gunderson EP, Habel L, Jones L, Newman VA, Rock CL, Slattery ML, Stefanick ML, Sternfeld B, Thomson CA, Pierce JP. Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat. 2006;99:47–57.

    Article  PubMed  Google Scholar 

  18. Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, Holick CN, Hampton JM, Stampfer MJ, Willett WC, Newcomb PA. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev. 2009;18:1403–9.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Chen X, Lu W, Zheng W, Gu K, Chen Z, Zheng Y, Shu XO. Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat. 2010;122:823–33.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Thivat E, Thérondel S, Lapirot O, Abrial C, Gimbergues P, Gadéa E, Planchat E, Kwiatkowski F, Mouret-Reynier MA, Chollet P, Durando X. Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer. 2010;10:648.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Caan BJ, Kwan ML, Shu XO, Pierce JP, Patterson RE, Nechuta SJ, Poole EM, Kroenke CH, Weltzien EK, Flatt SW, Quesenberry CP Jr, Holmes MD, Chen WY. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2012;21:1260–71.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Chilcott J, Lloyd Jones M, Wilkinson A. Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisal. Health Technol Assess. 2009;13:7–13.

    PubMed  Google Scholar 

  23. Lee SG, Jee YG, Chung HC, Kim SB, Ro J, Im YH, Im SA, Seo JH. Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC). Breast Cancer Res Treat. 2009;114:589–95.

    Article  CAS  PubMed  Google Scholar 

  24. World Health Organization. BMI classification. 2010. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html. 17 Jun 2013.

  25. Fornier MN, Modi S, Panageas KS, Norton L, Hudis C. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer. 2005;104:1575–9.

    Article  CAS  PubMed  Google Scholar 

  26. Rosendahl M, Ahlgren J, Andersen J, Bergh J, Blomquist C, Lidbrink E, Lindman H, Mouridsen H, Bjerre K, Andersson M. The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study. Eur J Cancer. 2009;45:3198–204.

    Article  CAS  PubMed  Google Scholar 

  27. Han HS, Lee KW, Kim JH, Kim SW, Kim IA, Oh DY, Im SA, Bang SM, Lee JS. Weight changes after adjuvant treatment in Korean women with early breast cancer. Breast Cancer Res Treat. 2009;114:147–53.

    Article  CAS  PubMed  Google Scholar 

  28. Martín M, Lluch A, Seguí MA, Ruiz A, Ramos M, Adrover E, Rodríguez-Lescure A, Grosse R, Calvo L, Fernandez-Chacón C, Roset M, Antón A, Isla D, del Prado PM, Iglesias L, Zaluski J, Arcusa A, López-Vega JM, Muñoz M, Mel JR. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. Ann Oncol. 2006;17:1205–12.

    Article  PubMed  Google Scholar 

  29. Hatam N, Ahmadloo N, Ahmad Kia Daliri A, Bastani P, Askarian M M. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil). Arch Gynecol Obstet. 2011;284:215–20.

    Article  CAS  PubMed  Google Scholar 

  30. Heasman KZ, Sutherland HJ, Campbell JA, Elhakim T, Boyd NF. Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat. 1985;5:195–200.

    Article  CAS  PubMed  Google Scholar 

  31. Baker J, Ajani J, Scotté F, Winther D, Martin M, Aapro MS, von Minckwitz G. Docetaxel-related side effects and their management. Eur J Oncol Nurs. 2008;12:253–68.

    Article  PubMed  Google Scholar 

  32. Freedman RJ, Aziz N, Albanes D, Hartman T, Danforth D, Hill S, Sebring N, Reynolds JC, Yanovski JA. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab. 2004;89:2248–53.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Statistical analysis support was provided by the Catholic Research Coordinating Center of the Korea Health 21 R&D Project (A070001), Ministry of Health and Welfare, Republic of Korea.

Conflict of interest

The authors indicate no potential conflicts of interest.

Author information

Authors and Affiliations

  1. Division of Breast and Thyroid Surgical Oncology, Department of Surgery, St. Vincent’s Hospital, The Catholic University of Korea, 93 Joongboo-Daero Paldal-gu, Suwon, Kyounggi-do, 442-723, Korea

    Ye Won Jeon, Seung Taek Lim & Young Jin Suh

  2. Department of Pathology, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, Korea

    Hyun Joo Choi

Authors
  1. Ye Won Jeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seung Taek Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hyun Joo Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Young Jin Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Young Jin Suh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeon, Y.W., Lim, S.T., Choi, H.J. et al. Weight change and its impact on prognosis after adjuvant TAC (docetaxel–doxorubicin–cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer. Med Oncol 31, 849 (2014). https://doi.org/10.1007/s12032-014-0849-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0849-z

Keywords

Search

Navigation